(Q42986655)

12 November 2017

0 references

Prostaglandin E2's new trick: "decider" of differential alveolar cell life and death (English)

1 reference

12 November 2017

1

1 reference

12 November 2017

2

Marc Peters-Golden

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

12 November 2017

published in

1 reference

12 November 2017

volume

182

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

2-3

1 reference

Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Prostaglandin E(2) induces fibroblast apoptosis by modulating multiple survival pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Apoptosis during wound healing, fibrocontractive diseases and vascular wall injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Evolving concepts of apoptosis in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Combinatorial activation of FAK and AKT by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Defect of hepatocyte growth factor secretion by fibroblasts in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Severity of lung injury in cyclooxygenase-2-deficient mice is dependent on reduced prostaglandin E(2) production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Bleomycin-induced E prostanoid receptor changes alter fibroblast responses to prostaglandin E2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Prostaglandin E2 reduces radiation-induced epithelial apoptosis through a mechanism involving AKT activation and bax translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201002-0239ED

10.1164/RCCM.201002-0239ED

21 January 2018

Identifiers

DOI

1 reference

release_r7rtni6x2fek3ez72x3lc2re7q

12 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/r7rtni6x2fek3ez72x3lc2re7q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference